Do all individuals with type 2 diabetes mellitus prefer decentralisation in clinical trials? Findings from a discrete choice experiment.

Kopanz J, Veldwijk J, Lagerwaard B, Mader JK, Tews D, van Sloten TT, Grobbee DE, Zuidgeest MGP, Trials@Home consortium

Open source

DOI
10.1136/bmjopen-2026-116239
Published
2026 Jul 15
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-116239,
  title = {Do all individuals with type 2 diabetes mellitus prefer decentralisation in clinical trials? Findings from a discrete choice experiment.},
  author = {Kopanz J and Veldwijk J and Lagerwaard B and Mader JK and Tews D and van Sloten TT and Grobbee DE and Zuidgeest MGP and Trials@Home consortium},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2026-116239},
  url = {https://doi.org/10.1136/bmjopen-2026-116239}
}

RIS

TY  - JOUR
TI  - Do all individuals with type 2 diabetes mellitus prefer decentralisation in clinical trials? Findings from a discrete choice experiment.
AU  - Kopanz J
AU  - Veldwijk J
AU  - Lagerwaard B
AU  - Mader JK
AU  - Tews D
AU  - van Sloten TT
AU  - Grobbee DE
AU  - Zuidgeest MGP
AU  - Trials@Home consortium
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-116239
UR  - https://doi.org/10.1136/bmjopen-2026-116239
ER  - 

APA

J, K., J, V., B, L., JK, M., D, T., TT, V. S., DE, G., MGP, Z., & consortium, T. (2026). Do all individuals with type 2 diabetes mellitus prefer decentralisation in clinical trials? Findings from a discrete choice experiment.. BMJ open. https://doi.org/10.1136/bmjopen-2026-116239

Source records